Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy.
about
Enzyme replacement therapy for Anderson-Fabry diseaseEnzyme replacement therapy for Anderson-Fabry diseaseEnzyme replacement therapy for Anderson-Fabry diseaseGastrointestinal involvement in Fabry disease. So important, yet often neglected.Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectional surveyImprovement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry.Gastrointestinal Symptoms of Patients with Fabry Disease.Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.Active-site-specific chaperone therapy for Fabry disease. Yin and Yang of enzyme inhibitors.Early therapeutic intervention in females with Fabry disease?The Pathobiochemistry of Gastrointestinal Symptoms in a Patient with Niemann-Pick Type C Disease.Lysosomal storage disease: revealing lysosomal function and physiology.Fabry disease: a review of current management strategies.The Coexistence of Multiple Myeloma-associated Amyloid Light-chain Amyloidosis and Fabry Disease in a Hemodialysis PatientBone and joint involvement in Fabry disease.Therapeutic goals in the treatment of Fabry disease.Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial.
P2860
Q24200877-52529D41-E79C-421B-9FD0-E072EE2820E1Q24235483-94D13534-4F4B-4206-A24E-0202E55E9B0AQ26471010-718D52B2-264D-4403-A16B-F3053CC5E157Q30991194-3CFF3147-1608-4CDA-A310-EB320643F07CQ34560232-1C6B25C0-52B1-4063-90F2-503AA6F92E86Q36373029-6BC5B73D-FBA3-4C1E-8B4E-5C66A98F271DQ36529707-2E01C625-C740-4603-9DFE-69E5A6C0D061Q36596408-5A48E928-DEBA-48E3-923B-98A9935D40E4Q36951293-C5CF1215-516D-4E72-860C-44500DBEE4E6Q37109597-834FFBAA-29D2-41B9-9136-044B5BAD9DFEQ37329179-56D4D04F-59F3-45FB-99F0-FB936124F1F4Q37739706-10840132-D99C-4FB7-BF91-3CB97B0253E1Q37775790-E77A8AD1-05A9-4392-8F88-41FC463C4911Q42223734-4001157E-5311-4EA4-8518-2083B0227833Q42642413-69796A86-FBE9-4655-84B3-3C23DA9B630DQ50436079-1FB94022-A6B1-4391-A7BF-27CB79AC2F8CQ55383790-80A09381-9266-4D29-8BB7-52E8A756A174
P2860
Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Gastrointestinal manifestation ...... to enzyme replacement therapy.
@ast
Gastrointestinal manifestation ...... to enzyme replacement therapy.
@en
type
label
Gastrointestinal manifestation ...... to enzyme replacement therapy.
@ast
Gastrointestinal manifestation ...... to enzyme replacement therapy.
@en
prefLabel
Gastrointestinal manifestation ...... to enzyme replacement therapy.
@ast
Gastrointestinal manifestation ...... to enzyme replacement therapy.
@en
P2093
P1476
Gastrointestinal manifestation ...... to enzyme replacement therapy.
@en
P2093
Maryam Banikazemi
Robert J Desnick
Thomas Ullman
P304
P356
10.1016/J.YMGME.2005.04.009
P577
2005-08-01T00:00:00Z